This educational activity is intended to help clinicians identify patients with thyroid eye disease (TED) who require intervention for elevated blood glucose levels prior to treatment for TED with the insulin-like growth factor 1 receptor antagonist teprotumumab. Clinicians will also learn to apply evidence to manage patients who require intervention for glycemic control during treatment for TED with teprotumumab. The desired results of this activity are for eye care professionals to use a multidisciplinary approach to increase their ability to identify and manage hyperglycemia in patients who require treatment of TED.
- Provider:MedEdicus, LLC
- Activity Link: https://courses.mededicus.com/content/thyroid-eye-disease-multidisciplinary-management-treatment-associated-hyperglycemia-cme#group-tabs-node-course-default1
- Start Date: 2024-01-31 06:00:00
- End Date: 2024-01-31 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.5 hours
- Commercial Support: Source: Amgen, Inc. - Amount: 176700.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Competence
- Provider Ship: Directly Provided
- Registration: Limited
Subscribe
Login
0 Comments
Oldest